by adam@design812.com | Sep 21, 2024 | Success Stories
The study drug Aimovig is now FDA Approved. MediSphere conducted this Migraine trial in 2015-2017. Welcome news to some of the millions of Americans who suffer from potentially debilitating migraine headaches! The new drug, Aimovig, was produced by Amgen and approved... 
by adam@design812.com | Sep 21, 2024 | Success Stories
On November 21st, 2016 the U.S. Food and Drug Administration approved SOLIQUA™ 100/33. SOLIQUA 100/33 is an injectable prescription medicine that contains 2 diabetes medicines, insulin glargine and lixisenatide, that may improve blood sugar (glucose) control in adults... 
by adam@design812.com | Sep 21, 2024 | Success Stories
Erenumab Co-Developed by Amgen and Novartis for Episodic Migraine PreventionPharmaceutical company, Amgen, has announced positive top-line results for erenumab from a global Phase 3, STudy to evaluate the efficacy and safety of erenumab in migRaIne preVEntion... 
by adam@design812.com | Sep 21, 2024 | Success Stories
Another successful trial at MediSphere Medical Research Center, LLC: The U.S. Food and Drug Administration (FDA) has approved Trulance™ (plecanatide) for the treatment of adults with chronic constipation of unknown cause (CIC). Trulance™ is the first drug designed to...